The technology giant has begun the year with some big news and looks ready to make 2014 a year of exciting changes and developments. Microsoft (MSFT) has announced a new CEO, a new role for its founder, Bill Gates (Trades, Portfolio), and is ready to refocus its business strategy and prepare for expansion into new markets.
The New CEO
The company�� stock was boosted more than 1% immediately following the official announcement of Satya Nadella��ormer head of Microsoft�� cloud and enterprise business��s the new chief executive officer.
The decision comes after months of anticipation about who would take the place of Steve Ballmer who had announced his retirement back in August of last year. Since the former CEO announced his plans to retire, the stock has risen more than 13% and managed to maintain this increase through the months of uncertainty and speculation about who would become the third head of the 40 year old company.
As former head of the cloud and enterprise business, Nadella�� expertise lies primarily in the areas of research and product development. Because of this, there is some concern about whether or not he will be able to form a business strategy that is driven by sales and marketing.
Top Regional Bank Companies To Watch For 2016: OncoMed Pharmaceuticals Inc (OMED)
OncoMed Pharmaceuticals, Inc. (OncoMed) incorporated on July 19, 2004, is a clinical development-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells (CSCs). It utilizes its technologies to identify, isolate and evaluate CSCs; identify and/or validate multiple potential targets and pathways critical to CSC self-renewal and differentiation; and develop targeted antibody and other protein-based therapeutics that are designed to modulate these CSC targets and inhibit the growth of CSCs. The Company's anti-cancer therapeutics include anti-DLL4 (demcizumab, OMP-21M18), Anti-DLL4/Anti-VEGF Bispecific, and Anti-Notch2/3 (OMP-59R5), Anti-Notch1 (OMP-52M51, Anti-Fzd7, Fzd8-Fc, RSPO-LGR.
Anti-DLL4 (demcizumab, OMP-21M18) is a humanized monoclonal antibody that inhibits Delta Like Ligand 4 (DLL4) in the Notch signaling pathway. The Company has completed a single-agent Phase Ia trial in advanced solid tumor patients. The Company focuses on conducting two Phase Ib combination trials of demcizumab. Anti-DLL4/anti-VEGF bispecific is a monoclonal antibody that targets and inhibits both DLL4 and vascular endothelial growth factor ( VEGF). VEGF is the target of Avastin. Anti-Notch2/3 (OMP-59R5) is a human monoclonal antibody that targets the Notch2 and Notch3 receptors.
Anti-Notch1 OMP-52M51 is a humanized monoclonal antibody targeted to the Notch1 receptor. Anti-Fzd7 OMP-18R5 is a human monoclonal antibody identified by screening against the Frizzled7 receptor (Fzd7) that binds a conserved epitope on five Frizzled receptors and inhibits Wnt signaling. OMP-18R5 is in a Phase I single-agent trial in advanced solid tumor patients. Fzd8-Fc OMP-54F28 is a fusion protein based on a truncated form of the Frizzled8 receptor ( Fzd8). RSPO-LGR ligands signal through the LGR receptor family.
The Company utilizes several robust technologies for the discovery and optimization of its antibody and protein-bas! ed therapeutics, including multiple proprietary technologies. Its antibody technologies include Mammalian Display Technology, Bispecific Antibody Technology, Hybridoma Technology. Mammalian Display Technology utilizes flow cytometry to isolate mammalian cells expressing antibodies on the cell surface with desired characteristics from large libraries of candidate antibodies. Bispecific Antibody Technology is used to generate its anti-DLL4/anti-VEGF antibody. Hybridoma Technology is used for isolating antibodies from mice, including multiplex single-cell screening techniques.
Advisors' Opinion:- [By Garrett Cook]
OncoMed Pharmaceuticals (NASDAQ: OMED) shares tumbled 12.05 percent to $20.90 after the company voluntarily stopped enrollment for Phase 1 Vantictumab.
- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
The U.S. Food and Drug Administration on Wednesday imposed a partial clinical hold on a second cancer treatment trial by OncoMed Pharmaceuticals Inc.(OMED) The FDA’s action follows a similar hold last Friday on another treatment targeting cancer stem cells.
- [By Jake L'Ecuyer]
Equities Trading UP
OncoMed Pharmaceuticals (NASDAQ: OMED) shot up 8.62 percent to $30.09 after the company initiated Phase 1B trial of WNT-parthway-target antibody. Jefferies lifted the price target on the stock from $27 to $46. - [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are OncoMed Pharmaceuticals Inc.(OMED), Lexicon Pharmaceuticals Inc.(LXRX) and Krispy Kreme Doughnuts Inc.(KKD)
Top 10 Dow Dividend Companies To Own For 2015: Alon USA Partners LP (ALDW)
Alon USA Partners, LP (Alon USA), incorporated on August 17, 2012, owns and operates refining and petroleum products marketing business. Its integrated downstream business operates primarily in the South Central and Southwestern regions of the United States. It owns and operates a crude oil refinery in Big Spring, Texas with total throughput capacity of approximately 70,000 barrels per day (bpd). The crude oil pipelines the Company utilizes consist of the Amdel, White Oil, Mesa Interconnect, Centurion and Centurion Interconnect. Its Big Spring refinery produces ultra-low sulfur gasoline, ultra-low sulfur diesel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt and other petroleum products.
During the year ended December 31, 2011 and the six months ended June 30, 2012, sour crude, such as West Texas Sour (WTS), represented approximately 80.4% and 80.4% of its throughput, respectively, and sweet crude, such as West Texas Intermediate (WTI), represented approximately 15.8% and 17.1% of its throughput, respectively. For the year ended December 31, 2011 and the six months ended June 30, 2012, the Company produced approximately 49.1% and 49.2% gasoline, 32.3% and 32.5% diesel/jet fuel, 7.1% and 6.4% asphalt, 6.0% and 6.0% petrochemicals and 5.5% and 5.9% other refined products, in each case, respectively. The Company distributes fuel products through a product pipeline and terminal network of seven pipelines totaling approximately 840 miles and six terminals that it owns or access.
The Company competes with Chevron, ExxonMobil and Shell.
Advisors' Opinion:- [By Robert Rapier] In last week’s issue I discussed the basics of the refining sector. Today I will provide an overview of four MLPs that hold refining assets.
To review, the refining sector was very profitable in 2012 thanks to unusually high crack spreads, which for many US refiners are approximated by the price differential between Brent and West Texas Intermediate (WTI) crude oils. For a more thorough explanation of this phenomenon, please refer to last week’s issue.
After years of trading at a $1 to $3 per barrel discount to WTI, Brent began fetching a premium a few years ago as a glut of crude developed in the mid-continent area of the US. In 2011 the Brent-WTI price differential increased to more than $25/bbl, and it remained historically high in 2012.
But pipeline capacity started to catch up this year, and the share prices of refiners retreated as the glut began to dissipate and the Brent-WTI differential shrank. In Q3 2012, the Brent-WTI differential averaged $17.43/bbl, but by Q3 of this year, the differential had fallen to $4.43/bbl. This promises bad news for refiners about to report Q3 earnings.
Many analysts downgraded the refining sector in Q3, but as the differential fell below $5/bbl it was hard to imagine that the news could get much worse. With poor Q3 results largely priced in, the differential subsequently rose back above $10/bbl, signaling better refining margins moving into Q4.
Refiners began to post earnings this past week, and as expected they were weak. Valero (NYSE: VLO) reported slightly higher revenues year-over-year, but net earnings fell more than 50 percent from a year ago. Nevertheless, they beat the extremely pessimistic expectations of analysts, and Valero shares rose on the news.
Phillips 66’s (NYSE: PSX) refining unit actually posted a loss, but its chemical business turned in a solid quarter which more than compensated for the disappointing refining results.
The rest of the refine
Top 10 Dow Dividend Companies To Own For 2015: China Mobile Games and Entertainment Group Ltd (CMGE)
China Mobile Games and Entertainment Group Limited, incorporated on January 20, 2011, is a holding company. The Company is engaged in the development, operation and sale of feature phone and smartphone games, as well as the provision of handset design products and services. The Company operates in three segments: feature phone games, smartphone games and handset design. As of December 31, 2011, it was a subsidiary of VODone Limited.
CMGEconducts its primary business operations through its subsidiaries and a variable interest entity (VIE). Kangri Yingxiong Zhuan is a single-player smartphone game, which was launched during the year ended December 31, 2011.Paopao Xiyou, YY Three Kingdoms, Thumb Monopoly and Creation Song are its smartphone mobile social games. Xiao'ao Jianghu is its internally-developed feature phone mobile social game. The Company has a diversified portfolio of games for feature phones and smartphones. As of March 31, 2012, the Company�� portfolio included 450 mobile games, of which 130 of its 136 feature phone games were developed in-house; it licensed 302 of its 314 smartphone games from third parties and it developed its smartphone mobile social games in-house.
On February 14, 2012, the Company established four wholly owned subsidiaries, which included HYD Holding Limited, OWX Group Limited, OWX Development Limited and 3GUU Holding Limited. On March 23, 2012, CMGE transferred all of the interests in Beauty Wave Limited (Beauty Wave) and China Wave Group Limited (China Wave) to HYD Holding Limited; transferred all of the interests in OWX Hong Kong Limited (OWX HK) to OWX Development Limited, and transferred all of the interest in 3GUU Mobile Entertainment Industrial Co. Ltd. (3GUU BVI) to 3GUU Holding Limited.
The Company generates feature phone games revenues principally from the sale of in-game features of mobile phone games on feature phones. The Company generates smartphone game revenues from the sale of in-game premium features of mobile ! social games that it develops in-house, as well as from the sale of single-player games on smartphones that it develops in-house and license or acquire. CMGE operates mobile social games and single-player games under a free-to-play model and a subscription-based model, respectively. The Company contracts with third-party payment platforms for billing, collection and transmission services offered to mobile phone game players who have purchased game points. It also contracts with mobile application and software Websites to distribute its mobile social games by providing platforms for mobile phone game players to download such games.
CMGE generates handset design revenues from the provision of handset design solutions to mobile phone manufacturers and mobile phone content providers. Handset design solutions include operating system software and hardware design with one-year post-contract customer support (PCS) service; printed circuit board with operating system software and optional assembly service, and mobile phone contents installation service. Operating system software and hardware designs with PCS services are provided to mobile phone manufacturers for either a fixed fee or a variable fee based on the units of production by the mobile phone manufacturers at a prescribed unit price. Printed circuit boards with operating system software are sold to mobile phone manufacturers for a fixed unit price. Mobile phone contents installation services are rendered to mobile phone content providers for a prescribed percentage of the mobile phone content providers' net profits.
Advisors' Opinion:- [By Monica Gerson]
China Mobile Games and Entertainment Group (NASDAQ: CMGE) is projected to report its Q2 earnings at $0.21 per share on revenue of $43.60 million.
Rediff.com India (NASDAQ: REDF) is estimated to report its Q1 earnings.
Top 10 Dow Dividend Companies To Own For 2015: Collectors Universe Inc. (CLCT)
Collectors Universe, Inc. provides authentication and grading services to dealers and collectors of high-value coins, trading cards, event tickets, autographs, memorabilia, and stamps in the United States. It offers authentication and grading services for coins under the Professional Coin Grading Service brand name; sports and trading cards under the Professional Sports Authenticator (PSA) brand name; vintage autographs and memorabilia under the PSA/DNA authentication services brand name; and stamps under the Professional Stamp Experts brand name. The company also publishes authoritative price guides, rarity reports, and other collectibles data to provide collectors with information. In addition, it operates the Certified Coin Exchange business-to-business Website, certifiedcoinexchange.com, where dealers can sell and purchase certified coins and other certified collectibles; and Collectors Corner Business-to-Consumer Website, collectorscorner.com, a business-to-consumer W ebsite where consumers can visit, identify, search, sort over, and select for purchase coins, trading cards, and items of currency that are certified by the company, as well as Collectors Clubs for coin, currency, and trading card collectors; and manages and operates collectibles trade shows and conventions. The company provides its services to dealers, collectors, and retail buyers and sellers of collectibles. Collectors Universe, Inc. was founded in 1986 and is headquartered in Santa Ana, California.
Advisors' Opinion:- [By Jeff Hwang]
Such multiple expansion may be a natural product of time (i.e., older cards naturally carry larger premiums over time), or more likely a combination of time and the card removal effect. That is, over time, the best examples of a given card get graded by Beckett Grading Services or Professional Sports Authenticator (PSA), a division of Collectors Universe (NASDAQ: CLCT ) , and are thus removed from the pool of ungraded cards; as a consequence, the value of ungraded cards declines in relation to the value of graded cards (or the value of graded cards rises in relation to ungraded cards), resulting in multiple expansion.
Top 10 Dow Dividend Companies To Own For 2015: OCI Partners LP (OCIP)
OCI Partners LP, incorporated on February 07, 2013, owns and operates an integrated methanol and ammonia production facility that is strategically located on the Texas Gulf Coast near Beaumont. The Company is a methanol producer in the United States with an annual methanol production capacity of approximately 730,000 metric tons and an annual ammonia production capacity of approximately 265,000 metric tons, and it is in the early stages of a debottlenecking project that increases its annual methanol production capacity by 25% to approximately 912,500 metric tons and its annual ammonia production capacity by 15% to approximately 305,000 metric tons.
Both methanol and ammonia are global commodities that are essential building blocks for numerous end-use products. Methanol is a liquid petrochemical that is used in a variety of industrial and energy-related applications. Methanol is used in industrial applications to produce adhesives used in manufacturing wood products, such as plywood, particle board and laminates, resins to treat paper and plastic products, paint and varnish removers, solvents for the textile industry and polyester fibers for clothing and carpeting. Methanol is also used outside of the United States as a direct fuel for automobile engines, as a fuel blended with gasoline and as an octane booster in reformulated gasoline. In the United States, ammonia is primarily used as a feedstock to produce nitrogen fertilizers, such as urea and ammonium sulfate, and is also directly applied to soil as a fertilizer. In addition, ammonia is widely used in industrial applications, particularly in the Texas Gulf Coast market, including in the production of plastics, synthetic fibers, resins and numerous other chemical compounds.
Advisors' Opinion:- [By Robert Rapier]
OCI Partners (Nasdaq: OCIP) owns and operates OCI Beaumont, an integrated methanol and ammonia production facility on the Texas Gulf Coast. OCI Beaumont has a methanol production capacity of 730,000 metric tons (MT) per year and an ammonia production capacity of 265,000 MT per year. The facility is in the middle of a debottlenecking project that will increase its annual methanol production capacity by 25 percent and its annual ammonia production capacity by 15 percent.
- [By Paul Ausick]
Stocks on the Move: Potbelly Corp. (NASDAQ: PBPB) is up 119.1% at $30.68 after a blistering IPO at $14 a share. OCI Partners LP (NYSE: OCIP) is up 5.6% at $19.01 after an IPO at $18.00 a share. Cherry Hill Mortgage Investment Corp. (NYSE: CHMI) is down 7.6% at $18.48 following its IPO on Friday morning. Discovery Laboratories Inc. (NASDAQ: DSCO) is up 37.1% at $2.70 following approval of updated specifications for a drug to prevent respiratory distress in premature infants. Forest Oil Corp. (NYSE: FST) is down 9.7% at $5.74 following the sale of $1 billion worth of assets in the Texas panhandle.
- [By Robert Rapier]
Rounding out the bottom five were�OCI Partners�(NYSE: OCIP), a methanol and ammonia producer (-24 percent YTD),�Natural Resource Partners�(NYSE: NRP), another coal producer (-19 percent), and�Eagle Rock Energy Partners�(NASDAQ: EROC), an oil and gas production partnership (-17 percent).
Top 10 Dow Dividend Companies To Own For 2015: EXFO Inc (EXFO)
EXFO Inc. provides next-generation test and service assurance solutions for wireline and wireless network operators and equipment manufacturers in the global telecommunications industry. It offers field-test platforms, including FTB-1 platform, a single-slot modular platform to fiber-optic, copper, Ethernet, fiber-to-the-home, and multiservice testing applications; FTB-200 compact platform, which include singlemode and multimode optical time-domain reflectometers, automated optical loss test sets, SONET/SDH analyzers up to 10 Gbit/s, and gigabit Ethernet and 10 gigabit Ethernet testers; and FTB-500 platform for datacom testing, OTDR analysis, optical loss, and Ethernet testing. The company also provides wireless test equipment comprising 2G, 3G, and 4G/LTE protocol analyzers that allow engineers to troubleshoot networks in order to find the source of errors and fix them. In addition, it offers wireline/wireless service assurance systems, including Brix System that delivers end-to-end quality of service and experience visibility, as well as real-time Internet protocol service monitoring and verification for next-generation networks. Further, EXFO Inc. provides IQS-600 platform to run various 100 optical test modules using a single controller unit; high-performance test modules; PSO-200 optical modulation analyzer; protocol analyzers for use in protocol analysis to verify correct network behavior; network simulators for regression and load testing applications; and mobile communications intelligence tools for police, armed forces, and other governmental organizations to fight organized crime and terrorists. The company sells its products through its direct sales force, sales representatives, and distributors. EXFO Inc. was founded in 1985 and is headquartered in Quebec, Canada.
Advisors' Opinion:- [By Monica Gerson]
EXFO (NASDAQ: EXFO) is expected to post its Q4 earnings at $0.05 per share on revenue of $60.94 million.
Yum! Brands (NYSE: YUM) is estimated to post its Q3 earnings at $0.93 per share on revenue of $3.53 billion.
Top 10 Dow Dividend Companies To Own For 2015: China Biologic Products Inc.(CBPO)
China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People?s Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers Human Hepatitis B Immunoglobulin for the prevention of measles and contagious hepatitis; Human Immunoglobulin and Human Immunoglobulin for Intravenous Injection products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides Injection that is used in the treatment of various original and sec ondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides Human Rabies Immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; Human Tetanus Immunoglobulin for the prevention and therapy of tetanus; and Placenta Polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company?s products under development comprise Human Prothrombin Complex Concentrate; Human Coagulation Factor VIII; Human Hepatitis B Immunoglobulin (PH4) for Intravenous Injection; Human Fibrinogen; Varicella Hyperimmune Globulins; and Human Immunoglobulin for Intravenous Injection. The company is based in Beijing, the People's Republic of China.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.
No comments:
Post a Comment